Cognoa

Headquarters

Founded Year

Company Status

Website

Operating Status

Social Media

Cognoa is a pioneering company in the field of early childhood development and pediatric behavioral health. They are dedicated to developing digital diagnostics and therapeutics that enable earlier and more equitable access to care, thereby improving the lives and outcomes of children and families. Their innovative, scientifically proven technology and whole-child approach are transforming the path to care. One of their breakthrough innovations is Canvas Dx, the first and only FDA-authorized diagnostic solution designed to equip healthcare providers to diagnose or rule out autism in children ages 1.5 to 6 years within days, not months or years.

Cognoa uses AI to identify risks for behavioral delays. Their platform employs machine learning technology to determine the most predictive data. In the case of diagnosing autism, Cognoa’s AI processes the data of three questionnaires: from the pediatrician, the parents, and an autism specialist who watches two short videos of the child filmed by parents in the Cognoa app. Then the pediatrician receives a result from the AI program, which they use to make a diagnosis. This innovative use of AI allows for early, rapid, and equitable diagnosis of autism and other developmental concerns.